[go: up one dir, main page]

Ahrén et al., 2004 - Google Patents

Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.

Ahrén et al., 2004

Document ID
7567336611856336977
Author
Ahrén B
Pacini G
Publication year
Publication venue
European Journal of Endocrinology

External Links

Snippet

Insulin sensitivity and insulin secretion are mutually related such that insulin resistance is compensated by increased insulin secretion. A correct judgement of insulin secretion therefore requires validation in relation to the insulin sensitivity in the same subject …
Continue reading at search.ebscohost.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications

Similar Documents

Publication Publication Date Title
Ahrén et al. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.
US11246986B2 (en) Integrated closed-loop medication delivery with error model and safety check
Pacini et al. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT
Pacini et al. Methods for clinical assessment of insulin sensitivity and β-cell function
Goland et al. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls
Caumo et al. First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Solomon Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose
De Vries et al. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia
Matsuda Measuring and estimating insulin resistance in clinical and research settings
Kang et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea
Karpe et al. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity
JP5501963B2 (en) System and computer program product for assessing insulin sensitivity, insulin / carbohydrate ratio, and insulin correction function in diabetes from self-monitoring data
Pacini et al. Methods and models for metabolic assessment in mice
Ahrén β-and α-cell dysfunction in subjects developing impaired glucose tolerance: Outcome of a 12-year prospective study in postmenopausal Caucasian women
CA2684717A1 (en) A method for determining insulin sensitivity and glucose absorption
Jochberger et al. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study
Blankenship et al. Managing free-living hyperglycemia with exercise or interrupted sitting in type 2 diabetes
Lotz et al. Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST)
Peterson et al. Type 2 diabetes, obesity, and sex difference affect the fate of glucose in the human heart
Scudder et al. Pasireotide for the medical management of feline hypersomatotropism
Laine et al. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men
Visentin et al. Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual-to a single-tracer oral minimal model
Ahrén et al. Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women
Dotson et al. Insulin stimulation reduces aortic wave reflection in adults with metabolic syndrome
Overgaard et al. Mathematical beta cell model for insulin secretion following IVGTT and OGTT